Corrigendum to “Predictors of complications following breast reduction surgery: A National Surgical Quality Improvement Program study of 16,812 cases” [J Plast Reconstr Aesthet Surg 72 (2019) 43–51]

Simpson, Andrew; Donato, Daniel P.; Kwok, Alvin C.; Agarwal, Jayant P.

doi:10.1016/j.bjps.2019.04.002

Cited by 10 publications

(26 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Finally, 85% of respondents would not recommend risk-reducing mastectomy for patients with BRCA deleterious mutations. These data agree with the recommendations to avoid or delay major surgery that could prolong hospitalization and increase complications or require further hospital admissions [ 47 – 53 ].…”

Section: Discussionsupporting

confidence: 86%

Management of early breast cancer during the COVID-19 pandemic in Brazil

Cavalcante

Novita²,

Millen

et al. 2020

Breast Cancer Res Treat

View full text Add to dashboard Cite

Purpose The COVID-19 pandemic has impacted early breast cancer (EBC) treatment worldwide. This study analyzed how Brazilian breast specialists are managing EBC. Methods An electronic survey was conducted with members of the Brazilian Society of Breast Cancer Specialists (SBM) between April 30 and May 11, 2020. Bivariate analysis was used to describe changes in how specialists managed EBC at the beginning and during the pandemic, according to breast cancer subtype and oncoplastic surgery. Results The response rate was 34.4% (503/1462 specialists). Most of the respondents (324; 64.4%) lived in a state capital city, were board-certified as breast specialists (395; 78.5%) and either worked in an academic institute or one associated with breast cancer treatment (390; 77.5%). The best response rate was from the southeast of the country (240; 47.7%) followed by the northeast (128; 25.4%). At the beginning of the pandemic, 43% changed their management approach. As the outbreak progressed, this proportion increased to 69.8% (p < 0.001). The southeast of the country (p = 0.005) and the state capital cities (p < 0.001) were associated with changes at the beginning of the pandemic, while being female (p = 0.001) was associated with changes during the pandemic. For hormone receptor-positive tumors with the best prognosis (Ki-67 < 20%), 47.9% and 17.7% of specialists would recommend neoadjuvant endocrine therapy for postmenopausal and premenopausal women, respectively. For tumors with poorer prognosis (Ki-67 > 30%), 34% and 10.9% would recommend it for postmenopausal and premenopausal women, respectively. Menopausal status significantly affected whether the specialists changed their approach (p < 0.00001). For tumors ≥ 1.0 cm, 42.9% of respondents would recommend neoadjuvant systemic therapy for triple-negative tumors and 39.6% for HER2 + tumors. Overall, 63.4% would recommend immediate total breast reconstruction, while only 3.4% would recommend autologous reconstruction. In breast-conserving surgery, 75% would recommend partial breast reconstruction; however, 54.1% would contraindicate mammoplasty. Furthermore, 84.9% of respondents would not recommend prophylactic mastectomy in cases of BRCA mutation. Conclusions Important changes occurred in EBC treatment, particularly for hormone receptor-positive tumors, as the outbreak progressed in each region. Systematic monitoring could assure appropriate breast cancer treatment, mitigating the impact of the pandemic.

show abstract

Section: Discussionsupporting

confidence: 86%

Management of early breast cancer during the COVID-19 pandemic in Brazil

Cavalcante

Novita²,

Millen

et al. 2020

Breast Cancer Res Treat

View full text Add to dashboard Cite

show abstract

“…This trend is apparent for numerous procedures recorded in the NSQIP and is often attributed to increased institutional enrollment. 43 To accurately assess trends in feminizing top surgeries while controlling for changes in enrollment; we compared the rate of reporting for transfeminine cases to that of laparoscopic cholecystectomy (Fig. 2).…”

Section: Resultsmentioning

confidence: 99%

Epidemiologic Characteristics and Postoperative Complications following Augmentation Mammaplasty: Comparison of Transgender and Cisgender Females

Cuccolo¹,

Kang²,

Boskey

et al. 2019

Plastic and Reconstructive Surgery - Global Open

View full text Add to dashboard Cite

Background:Breast augmentation in transgender women can be an important first step in addressing gender incongruence and improving psychosocial functioning. The aim of this study was to compare postoperative outcomes of augmentation mammoplasty in transgender and cisgender females.Methods:We queried the American College of Surgeons National Surgical Quality Improvement Program database from 2006 to 2017 to establish 2 cohorts: (1) transgender females undergoing gender-affirming breast augmentation (“top surgery”) and (2) cisgender females seeking cosmetic breast augmentation (CBA). Demographic characteristics and postoperative outcomes were compared between the 2 cohorts. Multivariable regression analysis was used to control for confounders.Results:A total of 1,360 cases were identified, of which 280 (21%) were feminizing top surgeries and 1,080 (79%) were CBA cases. The transfeminine cohort was significantly older, had a higher average body mass index, and was more racially diverse than the CBA cohort. Transfeminine patients also had higher rates of smoking, diabetes, and hypertension. The rates of all-cause complications were low in both cohorts, and differences were not significant (1.6% transfeminine versus 1.8% CBA, P = 0.890) for the first 30-days after operation. After controlling for confounding variables, transfeminine patients had postoperative complication profiles similar to their cisgender counterparts. Multivariable regression analysis revealed no statistically significant predictors for all-cause complications.Conclusions:Transfeminine breast augmentation is a safe procedure that has a similar 30-day complication profile to its cisgender counterpart. The results of this study should reassure and encourage surgeons who are considering performing this procedure.

show abstract

“…Increasing number of external ear reconstruction cases were noted each year (Table 3), which is typically attributed to increased institutional enrollment. 43…”

Section: Resultsmentioning

confidence: 99%

Reconstruction of Congenital Microtia and Anotia: Analysis of Practitioner Epidemiology and Postoperative Outcomes

Cuccolo

Zwierstra²,

Ibrahim³

et al. 2019

Plastic and Reconstructive Surgery - Global Open

View full text Add to dashboard Cite

Background: Microtia refers to a congenital malformation of the external ear that is associated with a range of functional, psychosocial, aesthetic, and financial burdens. The aim of this study was to analyze the epidemiology and postoperative complication profile of microtia reconstruction. Methods: A retrospective review was conducted using data from the 2012–2017 the American College of Surgeons National Quality Improvement Program Pediatric databases. Patients with a diagnosis of microtia or anotia were identified using International Classification of Diseases codes. Demographics and postoperative complications were analyzed using Chi-square and t tests for categorical and continuous variables, respectively. Multivariable regression was performed to control for confounding variables. Results: A total of 466 cases were analyzed, of which 290 (62.2%) were performed by plastic surgeons and 176 (37.8%) by otolaryngologists (ear, nose, and throat physicians [ENT]). Autologous reconstruction was the predominant approach [76.2% of cases (n = 355)] in this cohort. ENT physicians operated on a significantly younger patient population (mean age 8.4 ± 3.2 years versus 10.0 ± 3.2 years, P < 0.001) and had higher rates of concurrent atresia/middle ear repair [21.0% (n = 37) versus 3.7% (n = 17)] compared with plastic surgeons. The rate of all-cause complications was 5.9% (n = 17) in the plastic surgery cohort and 4.0% (n = 7) in the ENT cohort ( P = 0.372). Multivariable regression did not reveal any statistically significant predictors for all-cause complications. Conclusions: Reconstruction of the external ear for patients with microtia/anotia is a safe procedure, with low rates of postoperative complications, readmissions, and reoperations. Autologous reconstruction remains the preferred modality for repair of the external ear and simultaneous atresiaplasty/middle ear repair does not increase the risk of complications.

show abstract

Corrigendum to “Predictors of complications following breast reduction surgery: A National Surgical Quality Improvement Program study of 16,812 cases” [J Plast Reconstr Aesthet Surg 72 (2019) 43–51]

Cited by 10 publications

References 0 publications

Management of early breast cancer during the COVID-19 pandemic in Brazil

Management of early breast cancer during the COVID-19 pandemic in Brazil

Epidemiologic Characteristics and Postoperative Complications following Augmentation Mammaplasty: Comparison of Transgender and Cisgender Females

Reconstruction of Congenital Microtia and Anotia: Analysis of Practitioner Epidemiology and Postoperative Outcomes

Contact Info

Product

Resources

About